Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vomeronasal receptor type 2 (V2R) is a family of G protein-coupled receptors (GPCRs) belonging to the Class C (metabotropic glutamate receptor-like) group. These receptors are primarily expressed in the basal layer of the vomeronasal organ (VNO), a specialized chemosensory structure in many vertebrates [6, 14]. V2Rs are distinguished by a large extracellular N-terminal domain that facilitates the sensing of non-volatile peptide and protein ligands, such as major histocompatibility complex (MHC) peptides and major urinary proteins (MUPs) [12, 14]. In rodents and other mammals, V2R signaling is mediated through the G-protein subunit Gαo, leading to the activation of phospholipase C and the opening of TRPC2 ion channels [1, 11]. These interactions are essential for mediating social recognition, mate selection, and reproductive behaviors in diverse animal species [5, 13]. In humans, however, the V2R gene family has undergone comprehensive pseudogenization, and the VNO itself is considered vestigial or non-functional in adults [6, 9]. Due to this evolutionary loss of function, Vomeronasal receptor type 2 is not currently utilized as a therapeutic target in clinical medicine, and there are no approved pharmacological agents developed to interact with this receptor family in a human context [12].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vomeronasal receptor type 2 (V2R).